Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Why big pharma hasn't invested in unapproved peptides
Doctors who prescribe unapproved peptides – and the patients who take them – often have a ready-made response for when someone mentions the lack of clinical trial data to support their much-loved injectables. “It's because big…
AstraZeneca Pharma India Q1 profit drops to ₹37.93 crore
AstraZeneca Pharma India Ltd on Monday reported a 32 per cent decline in profit after tax at ₹37.93 crore in the June quarter, impacted by higher expenses. The company had posted a profit after tax of ₹55.83 crore in the corresponding…
Spain a 'value destination' for mid-market investors; Wise Equity to acquire E-Pharma Trento
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
Stocks to watch today: Signature Global, IndusInd Bank, pharma, railway and renewable energy stocks
Signature Global has awarded construction contracts worth Rs 920 crore to KEC International Ltd (Rs 460 crore) and NCC (Rs 460 crore), for its premium housing project ‘Sarvam at DXP Estate', located in Sector 37D, Dwarka Expressway…
Royal Bank of Canada Purchases 23,479 Shares of Royalty Pharma PLC $RPRX
Royal Bank of Canada boosted its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 15.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned…
Q3 EPS Estimates for Urogen Pharma Lifted by HC Wainwright
3 Bullish Biotech Stocks With Explosive Growth Trends Urogen Pharma (NASDAQ:URGN - Free Report) - Research analysts at HC Wainwright lifted their Q3 2026 EPS estimates for shares of Urogen Pharma in a research note issued on Thursday, August 6th.
Athira Pharma, Inc. (NASDAQ:LONA) Receives Consensus Recommendation of 'Moderate Buy' from Analysts
Athira Pharma, Inc. (NASDAQ:LONA - Get Free Report) has been given an average recommendation of 'Moderate Buy' by the six research firms that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the…
Ralph Lauren Posts Another Earnings Beat, As Bull Case Is Reaffirmed On Durability
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
HC Wainwright Issues Pessimistic Outlook for NAMS Earnings
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) - HC Wainwright lowered their Q3 2026 EPS estimates for NewAmsterdam Pharma in a report issued on Thursday, August 6th. HC Wainwright analyst L. Egana-Gorrono now expects that the company…
Mutual Fund flows and takeaways for you
Mutual Funds (MFs) come in multiple categories, spanning equity, debt and hybrid structures. Tracking categories receiving more flows than others gives us a clue on what a majority of investors are preferring at a point in time. You have to gauge…
Top Growth Stocks To Follow Now - August 9th
Prologis Q1 2026: Data Centers Steal the Show Prologis, Teledyne Technologies, Hamilton Lane, Ascendis Pharma A/S, Digital Turbine, Jersey Mike's, and Pattern Group are the seven Growth stocks to watch today, according to MarketBeat's stock…
Games about sorting 1000s of mundane objects onto shelves is the new craze sweeping PC gaming
Games about cleaning are the rage. The recent success of House Flipper, Power Wash Simulator and Unpacking demonstrates there's a mainstream-sized appetite among PC gamers for making messy places neat and tidy. But the micro-genre goes back way…
Molbio Diagnostics IPO: Analyst recommendations-should you subscribe or give it a miss?
The initial pubic offering of Temasek and Motilal Oswal Private Equity-backed Molbio Diagnostics opens today at a price band of Rs 768-807 a share. The ₹939.70-crore IPO closes on Wednesday. Up to 50% of the net offer is reserved for…
Dhoot Transmissions IPO opens today: Should you subscribe at ₹829-871? What brokerages say
Bain Capital-backed Dhoot Transmissions' initial public offering opens today for public subscription with a price band of ₹829-871 a share. The IPO closes on Wednesday, and the market lot is 17 shares. The total issue size is ₹3,067…
Waters Q2 Earnings Call Highlights
Agilent Technologies Thrives From the Forever Chemicals Crackdown Waters NYSE: WAT reported second-quarter 2026 revenue of $1.645 billion, driven by 9% organic constant-currency growth and a 4% increase in revenue from its acquired Biosciences and…
Receive a Daily briefing on Pharma Industry News
Get Started